Absolute Return Capital’s Edwards Lifesciences EW Stock Holding History

Absolute Return Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-13,314	Closed	-$315K	–	130
2015 Q3	$315K	Sell	13,314 -97,020	-88%	-$2.34M	0.02%	401
2015 Q2	$2.62M	Sell	110,334 -303,684	-73%	-$6.85M	0.1%	243
2015 Q1	$9.83M	Sell	414,018 -333,192	-45%	-$7.47M	0.26%	123
2014 Q4	$15.9M	Sell	747,210 -923,832	-55%	-$18.6M	0.33%	93
2014 Q3	$28.4M	Buy	1,671,042 +388,098	+30%	+$6.13M	0.4%	71
2014 Q2	$18.4M	Sell	1,282,944 -496,812	-28%	-$6.73M	0.22%	142
2014 Q1	$22M	Sell	1,779,756 -439,200	-20%	-$5.07M	0.32%	99
2013 Q4	$24.3M	Buy	2,218,956 +1,300,476	+142%	+$14.7M	0.27%	116
2013 Q3	$10.7M	Buy	+918,480	New	+$10.7M	0.15%	200

Other funds holding EW

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Absolute Return Capital's EW Position: Q4 2015 in Review

Absolute Return Capital sold out of Edwards Lifesciences (EW) in Q4 2015, closing a stake of 13,314 shares — an estimated $315K sold.

Absolute Return Capital first reported a position in EW in Q3 2013 and held it in 9 quarters. The position peaked at $28.4M in Q3 2014. 604 funds tracked by Wall St. Rank hold EW as of Q4 2015.

Absolute Return Capital reported no remaining Edwards Lifesciences position as of Q4 2015 after selling out during the quarter.
Absolute Return Capital sold 13,314 Edwards Lifesciences shares in Q4 2015, an estimated $315K.
Absolute Return Capital first reported a position in Edwards Lifesciences in Q3 2013 and held it in 9 quarters.
Absolute Return Capital's Edwards Lifesciences position peaked at $28.4M in Q3 2014.
604 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on Absolute Return Capital's 13F filing for Q4 2015.